BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 31029509)

  • 1. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
    Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
    Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?
    Yao L; Li Y; Li T; Fu W; Chen G; Li Q; Tang X; Li J; Xiong Y
    Clin Orthop Relat Res; 2023 Dec; ():. PubMed ID: 38153106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee: a retrospective analysis of 30 patients.
    van der Heijden L; Mastboom MJ; Dijkstra PD; van de Sande MA
    Bone Joint J; 2014 Aug; 96-B(8):1111-8. PubMed ID: 25086129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of surgery in tenosynovial giant cell tumours as measured by patient-reported outcomes on quality of life and joint function.
    Verspoor FGM; Mastboom MJL; Hannink G; van der Graaf WTA; van de Sande MAJ; Schreuder HWB
    Bone Joint J; 2019 Mar; 101-B(3):272-280. PubMed ID: 30813787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers.
    Mastboom MJL; Staals EL; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Palmerini E; Schaap GR; Jutte PC; Aston W; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; van de Sande MAJ;
    J Bone Joint Surg Am; 2019 Jul; 101(14):1309-1318. PubMed ID: 31318811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigmented villonodular synovitis of the knee: A retrospective analysis of 214 cases at a UK tertiary referral centre.
    Patel KH; Gikas PD; Pollock RC; Carrington RW; Cannon SR; Skinner JA; Briggs TW; Aston WJS
    Knee; 2017 Aug; 24(4):808-815. PubMed ID: 28442184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The surgical outcome and recurrence rate of tenosynovial giant cell tumor in the elbow: a literature review.
    Al Farii H; Zhou S; Turcotte R
    J Shoulder Elbow Surg; 2019 Sep; 28(9):1835-1840. PubMed ID: 31447124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midterm outcomes of 18 patients with primary intra-articular diffuse tenosynovial giant cell tumor (TGCT) of the knee treated with complete arthroscopic synovectomy and postoperative low-dose radiotherapy at a mean follow-up of 68 months.
    Tie K; Wang H; Chen B; Yang X; Chen L
    Arch Orthop Trauma Surg; 2023 Apr; 143(4):2121-2127. PubMed ID: 35562595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors.
    Palmerini E; Staals EL; Maki RG; Pengo S; Cioffi A; Gambarotti M; Picci P; Daolio PA; Parafioriti A; Morris C; Antonescu CR; Gronchi A; Casali PG; Donati DM; Ferrari S; Stacchiotti S
    Eur J Cancer; 2015 Jan; 51(2):210-7. PubMed ID: 25465190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological and functional outcomes of modified arthroscopic resection for intra-articular tenosynovial giant cell tumor of the knee using multiple portals.
    Higa K; Uehara F; Azuma C; Oshiro H; Tome Y; Nishida K
    J Orthop Surg (Hong Kong); 2023; 31(3):10225536231220413. PubMed ID: 38051283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensile Anterior and Posterior Knee Exposure for Complete Synovectomy of Diffuse Tenosynovial Giant Cell Tumor (Pigmented Villonodular Synovitis).
    Lingamfelter M; Novaczyk ZB; Cheng EY
    JBJS Essent Surg Tech; 2022; 12(2):. PubMed ID: 36741035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inconclusive benefit of adjuvant
    Gortzak Y; Vitenberg M; Frenkel Rutenberg T; Kollender Y; Dadia S; Sternheim A; Morag G; Farkash U; Rath E; Kramer M; Drexler M
    Bone Joint J; 2018 Jul; 100-B(7):984-988. PubMed ID: 29954214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot.
    Tsukamoto S; Zucchini R; Staals EL; Mavrogenis AF; Akahane M; Palmerini E; Errani C; Tanaka Y
    Foot Ankle Surg; 2020 Oct; 26(7):822-827. PubMed ID: 31839476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcomes of Diffuse or Recurrent Tenosynovial Giant Cell Tumor Treated with Postoperative External Beam Radiation Therapy.
    Baniel C; Yoo CH; Jiang A; von Eyben R; Mohler DG; Ganjoo K; Bui N; Donaldson SS; Million L; van de Rijn M; Oh JM; Hiniker SM
    Pract Radiat Oncol; 2023; 13(3):e301-e307. PubMed ID: 36460182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined arthroscopic and open synovectomy for diffuse pigmented villonodular synovitis of the knee.
    Mollon B; Griffin AM; Ferguson PC; Wunder JS; Theodoropoulos J
    Knee Surg Sports Traumatol Arthrosc; 2016 Jan; 24(1):260-6. PubMed ID: 25308157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenosynovial Giant Cell Tumors in Children: A Similar Entity Compared With Adults.
    Mastboom MJL; Verspoor FGM; Uittenbogaard D; Schaap GR; Jutte PC; Schreuder HWB; van de Sande MAJ
    Clin Orthop Relat Res; 2018 Sep; 476(9):1803-1812. PubMed ID: 29494352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of tenosynovial giant cell tumour of the foot and ankle.
    Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
    Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
    Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
    Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct extra-articular invasion patterns of diffuse pigmented villonodular synovitis/tenosynovial giant cell tumor in the knee joints.
    Kim DE; Kim JM; Lee BS; Kim NK; Lee SH; Bin SI
    Knee Surg Sports Traumatol Arthrosc; 2018 Nov; 26(11):3508-3514. PubMed ID: 29637236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering the recurrence rate in pigmented villonodular synovitis: A series of 120 resections.
    Capellen CF; Tiling R; Klein A; Baur-Melnyk A; Knösel T; Birkenmaier C; Roeder F; Jansson V; Dürr HR
    Rheumatology (Oxford); 2018 Aug; 57(8):1448-1452. PubMed ID: 29788491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.